ArticleJournal of pharmacy & bioallied sciences2025
Labor Induction versus Expectant Management: Evaluating Maternal and Neonatal Outcomes in Low-Risk Nulliparous Women.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This study aimed to compare the maternal and neonatal outcomes of elective labor induction at 39 weeks with expectant management in low-risk nulliparous women. Materials and Methods: A randomized controlled trial was conducted at ACS Medical College and Hospital, Chennai, over 6 months. A total of 100 low-risk nulliparous women with singleton pregnancies between 38 weeks 0 days and 38 weeks 6 days of gestation were randomized into two groups: labor induction ( Results: The labor induction group had a shorter labor duration (7.5 ± 2.3 vs. 9.2 ± 2.7 h; Conclusion: Labor induction at 39 weeks in low-risk nulliparous women shortens labor duration without increasing cesarean delivery rates, maternal complications, or adverse neonatal outcomes. These findings support the safety of elective labor induction in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.